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Allergic rhinitis (AR) remains a significant pediatric health 
problem because of the burden of uncontrolled symptoms 
on daily activities and on general well being. Aim: to assess 
the impact of AR on health-related quality of life (HRQL) 
of children and adolescents using a generic instrument, 
the Child Health Questionnaire (CHQ - PF50). Methods: 
Between January and November 2004, parents or caregivers 
of 23 children and adolescents with AR without comorbidities 
and with positive prick tests for at least one air allergen were 
invited to participate of a cross-sectional study and asked to 
answer the self-administered CHQ-PF50. The scores were 
compared to those of healthy children and adolescents. 
Results: Patient scores were lower (p<0.05) than healthy 
subsets in both the physical and psychosocial summaries 
and in most of the CHQ-PF50 scales (p<0,05), except for 
the “change in health” scale. The size effect was higher in 
the physical score compared to the psychosocial summary 
score. Conclusions: allergic rhinitis has a global negative 
impact on the HRQL of children and adolescents, with major 
repercussions in physical function; AR also negatively affects 
family relations.
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INTRODUCTION
Three fundamental reasons have been given for 
treating patients: to prolong life, to reduce morbidity and 
to seek well-being.1 Until recently, the success of therapy 
was evaluated only according to morbimortality rates. 
Measurements based on physiological and laboratory 
tests described the severity of disease, and well-being 
was believed to be the natural consequence of reducing 
such severity.2-4 However, evidence has shown that objects 
parameters correlate poorly or moderately with the well-
being of patients. A given clinical severity may have diver-
se effects on the well-being of different patients because of 
tolerance levels, health expectations and the ability to deal 
with disease-imposed limitations. Any evaluation should 
embody the subjective perceptions of patients about their 
own status and quality of life (QOL).2,5,6
The World Health Organization (WHO) defines 
QOL as “individuals’ perception of their position in life in 
the context of the culture and value systems in which they 
live and in relation to their goals, expectations, standards 
and concerns.”7 The term “health-related quality of life” 
(HRQL) derived mostly from a redefinition of health by the 
WHO in 1948: “a state of full physical, mental and social 
well-being, and not merely absence of illness or disease.”8
HRQL investigation includes features such as sub-
jectivity, multidimensionality (physical, psychological and 
social domains) and bipolarity (positive and negative 
domains, such as autonomy and dependence).7 Many 
questionnaires for assessing the HRQL have been tested; 
they are classified as generic or specific.2,9
Generic instruments comprise domains applicable 
to many diseases and population groups; it is possible 
to compare diagnoses and healthy x ill groups. Specific 
instruments assess the HRQL in diseases and/or specific 
populations; it is more sensitive for detecting change.9,10
Allergic rhinitis (AR) is one of the diseases of chil-
dhood that affects the HRQL. It is an inflammation of the 
nasal mucosa due to an IgE-mediated hypersensitivity 
reaction to specific allergens that occurs in genetically 
predisposed and sensitized individuals; one or more of the 
following symptoms may be present: nose block, watery 
rhinorrhea, sneezing, and nasal itching.11
The prevalence of this disease has increased in 
recent decades partly due to environmental exposure to 
allergens, altered life styles (more time spent in closed 
environments), and social and economic factors. World 
statistics show 30% to 40% prevalence in children and 
teenagers. Studies in Brazil have shown a 33% and 34% 
prevalence in school children aged 6-7 years and 13-14 
years.11 The prevalence was 24% among school-aged 
children (6-7 years) in the city of Uberlandia.12
Although there is a trend to underestimate the 
repercussions of AR on the QOL of individuals - because 
it is a benign disease that rarely requires hospitalization, 
surgery or complex interventions1,6 - AR may cause phy-
sical, psychological and social changes in patients, which 
need to be investigated.2,3,13-15
Assessments of the impact of AR on the HRQL 
became more common in the 1990s.1,4 The first such stu-
dies were carried out in adults, using generic and specific 
instruments.16-19 There were fewer studies done in chil-
dren and teenagers, only with specific questionnaires.20,21 
Nascimento Silva22 adapted and validated a specific ques-
tionnaire (RQLQ) for Brazilian adolescents with rhinitis. 
The current recommendation is to include HRQL studies 
using specific and generic instruments in clinical trials on 
chronic respiratory diseases, as well as investigation of 
objective clinical parameters such as pulmonary functions 
tests (asthma) and symptom evaluation scales (rhinitis).23,24
The purpose of this study was to assess the impact 
of AR on the HRQL of children and teenagers by applying 
a generic instrument - the Child Health Questionnaire 
(CHQ-PF50).
SERIES AND METHOD
A cross-sectional study was undertaken from Janu-
ary to November 2004, following approval by the local 
Research Ethics Committee (nº 095/2002).
 
Participants
Invitations were sent to parents or guardians of 
children aged over 5 years and teenagers with a diagnosis 
of AR for at least one year, based a the clinical history of 
suggestive symptoms (sneezing, rhinorrhea, nasal itching 
and/or obstruction) in suggestive circumstances (expo-
sure to known allergens) and with positive immediate 
hypersensitivity skin tests for at least one of the following 
aeroallergens: Blomia tropicalis, Dermatophagoides pte-
ronyssinus, Dermatophagoides farinae, storage acarid 
mites, fungi, pollen, feathers, Blatella germanica, wool, 
dog and cat epithelium.
Patients with other chronic diseases or comorbi-
dities that might have altered the HRQL investigation, 
such as asthma, atopic eczema, sinusitis, or food allergy, 
patients using medication that could alter the skin tests, 
and patients that refused the skin tests were excluded.
A control group was formed from a database of 
healthy children and teenagers with no history of respira-
tory allergies, evaluated during validation of the Brazilian 
version of the CHQ-PF50;21 these children were matched 
for age and sex in a 3:1 proportion for this study.
 
“Child Health Questionnaire - CHQ-PF50”
The “50-item, parent completed short form, Child 
Health Questionnaire” (CHQ-PF50) is a generic questio-
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nnaire for assessing the HRQL, applicable to children 
aged over 5 years and teenagers, in the perspective of 
parents or guardians. It was developed in Boston, US, 
between 1990 and 1996,25 and adapted culturally and 
validated for the Brazilian population.26,27 This instrument 
consists of 50 items distributed in 4 simple scales and 11 
multiple item scales; it encompasses 11 child domains 
and 4 family domains (Table 1). Scores range from 0 to 
100; highest scores indicate better functioning or feeling. 
There are two summary component scores of physical 
and psychosocial health.25
 
Procedure
Parents and guardians signed a free informed 
consent form adapted to the Portuguese language and 
answered a protocol with demographic data (sex, age, 
education level and number of siblings of child, education 
of informant and family monthly income) and information 
about the disease (severity and duration). The CHQ-PF50 
questionnaire was applied just before or immediately after 
a consultation, using a self-application technique.
Patients were asked to indicate an overall state of 
discomfort due to AR on an analog visual scale (AVS) 
measuring 100 mm with no subdivisions, where 0 was 
lack of discomfort and 100 was extreme discomfort. Dis-
comfort due to each symptom (nasal block, sneezing, 
coryza and nasal itching) was scored from 0 to 6, where 
0 was absence and 6 was extreme discomfort. Categories 
are subdivisions of 24 points, as follows: 0 (no discomfort), 
1-8 (mild discomfort), 9-16 (moderate-severe discomfort) 
and 17-24 (severe discomfort).
Patients were classified according to the severity 
of AR as mild and moderate-severe, according to the 
consensus criteria of the Allergic Rhinitis and its Impact 
on Asthma (ARIA).28
CHQ-PF50 scores of AR patients were compared 
with the control group scores and correlated with seve-
rity and overall discomfort of AR (AVS) and degree of 
discomfort due to each symptom.
The reliability of the instrument - verification of 
measurement errors and accuracy of scales and domains 
- was established by internal consistency, the degree by 
which items are interrelated.
 
Statistical analysis
Descriptive statistical analysis was applied to cha-
racterize social and demographic features of participants.
Internal consistency was measured using the Cron-
bach α coefficient. Cronbach’s α coefficient is based on 
the number of items in a scale and their homogeneity. 
For comparisons of groups, 0.5 to 0.7 (or more) minimal 
reliability measures are recommended.
Student’s t test was applied for comparing the 
scores of AR patients and healthy children and teenagers.
The effect size was applied to assess the magnitude 
of differences found in each scale and in the summary 
scores; the control group mean was subtracted from the 
mean of the study group and the result was divided by 
the standard deviation of the control group. A 0.20 to 
0.49 result was considered small, a 0.50 to 0.79 result was 
considered moderate, and a result of 0.80 or more was 
considered large.29
The point biserial correlation coefficient was ap-
plied to verify correlations among scales and summary 
scores in the CHQ and the AVS.
Pearson’s correlation coefficients (quantitative va-
riables) and Spearman’s correlation coefficients (qualita-
tive variables) were applied to verify correlations among 
scales and summary scores of the CHQ and disease se-
verity, and discomfort categories due to each symptom.
The significance level was 0.05.
RESULTS
Participants
There were 44 patients with a diagnosis of AR (wi-
thout asthma or other comorbidities) in the outpatient unit. 
Two of these abandoned the study, 6 were aged below 5 
years, 4 did not return the questionnaire, 5 had negative 
skin tests, and 4 did not answer the questionnaire, and 
were all excluded from the study. At the end there were 23 
questionnaires available for analysis. Twenty-one patients 
had persistent AR, and two patients had intermittent AR.
Informants were mostly mothers (86.95%). The 
mean age of patients was 9.22 years; most were male 
(78.26%). Table 2 shows additional features of the sample.
Cronbach’s alpha coefficients were above 0.7, ex-
cept for the perception of health scale (0.3).
Scores in the study group were lower compared to 
the control group, except for the change in health scale. 
The difference between groups was not significant only in 
the scales general behavior and family activities (p=0.108 
and p = 0.081). The size effect was significant in summary 
scores and in 10 scales, and moderate in 5 scales; it was 
higher in the physical summary score (1.83) compared to 
the psychosocial summary score (0.89) (Table 3).
The analog visual scale was positively correlated 
and significant in the general behavior scale (r=0.42) and 
negative and significant in the change in health scale (r= 
-0.52) (Table 4).
Disease severity and discomfort due to each symp-
tom did not correlate significantly with CHQ scores.
645
Brazilian Journal of otorhinolaryngology 75 (5) SeptemBer/octoBer 2009
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
Table 1. Interpretation of domain scores of the CHQ PF-50
Domain Low score High score
General health assessment In general, the child’s health is poor In general, the child’s health is excellent
Physical functioning*
Child is limited in carrying out all physical 
activities, including self-care, due to health 
issues
Child carries out all types of activities, 
including those that require effort, with no 
limits due to health issues
Limitation due to emotional aspects*
Child is limited in carrying out schoolwork 
and activities with friends due to emotional 
or behavioral issues
Child is not limited by emotional or beha-
vioral issues in schoolwork and activities 
with friends
Limitation due to the physical function*
Child is very limited in carrying out scho-
olwork or activities with friends due to 
physical health issues
Child is not limited by physical health 
issues in schoolwork or activities with 
friends
Bodily pain* Child has severe and frequent pain Child has no bodily pain 
Behavior*
Child often discusses, finds it hard to 
concentrate, lies, steals, is obstinate or 
irritated/willful
Child does not discuss, has no concentra-
tion problems, has not lied, stolen, beco-
me obstinate or irritated/willful
General behavior
Child behavior is poor compared to other 
children
Child’s behavior is excellent compared to 
other children
Mental health*
Child cries episodically, feels alone, ner-
vous, bothered or annoyed
Child has no episodes of crying, does not 
feel alone, nervous, bothered or annoyed
Self-esteem*
Child is not satisfied with abilities, appea-
rance, relationships and life in general
Child is satisfied with abilities, appearan-
ce, relationships and life in general
Perception of health
Parents believe that their child’s health is 
poor and tends to become worse
Parents believe that their child’s health is 
excellent and will continue to be
Change in health
Child’s health is poorer now compared to 
a year ago
Child’s health is better now compared to 
a year ago
Emotional impact on parents *
Parents are greatly concerned or bothered 
with the physical or psychosocial health of 
the child
Parents are not worried or bothered with 
the physical or emotional health of the 
child 
Time impact on parents*
Parents feel limited in their own needs due 
to the physical or psychosocial health of 
the child
Parents do not feel limited in their own 
needs because of the physical or psycho-
social health of the child
Family activities*
The child’s health often limit/interrupts 
family activities or causes distress
The child’s health never limits/interrupts 
family activities or causes distress
Family cohesion
The ability of the family to understand 
each other is poor
The ability of the family to understand 
each other is excellent
*Questions refer only to the past four weeks
DISCUSSION
This is the first study to assess the HRQL in children 
and teenagers with AR with the generic questionnaire 
CHQ-PF 50.
The internal consistency reliability of the instru-
ment items was adequate except for the perception of 
health scale, as also observed in the Brazilian version of 
the CHQ-PF50 for a healthy population, for subjects with 
juvenile idiopathic arthritis and with cerebral palsy.27,30,31 
This result may suggest issues with the cultural adaptation 
of this instrument or difficulty in understanding items of 
the scale.
The results show that AT has a negative multidi-
mensional impact on the HRQL. The repercussion is more 
pronounced in the physical health domain compared to 
the psychosocial domain (larger size effect in the phy-
sical summary score); this has been described in other 
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Table 2. General characteristics of participants
Characteristics Participants (n=23)
Mean age in years (range) 9,2 (5-14)
Male sex (%) 18 (78,3%)
Mean education level in years (range) 3,2 (0-7)
Mean number of siblings (range) 1 (0-5)
Severity of rhinitis (ARIA), n (%)  
 Mild 5 (21,7%)
Moderate - Severe 18 (78,3%)
Mean duration of disease in years (range) 5,2 (0,7-14)
General degree of discomfort caused by rhinitis (analog visual scale), mean (range) 53 (1,1-100)
Degree of discomfort of main symptoms, n (%)  
Mild 8 (34,8%)
Moderate - severe 12 (52,2%)
Severe 3 (13,0%)
Table 3. CHQ-PF50 scores in patients and controls
Scales and summaries - CHQ-PF50 
Controls (n = 69) Patients  (n= 23)
p value* Size effect
Mean
Standard 
deviation
Mean
Standard 
deviation
General health 93,26 12,03 62,17 25,26 0,000 2,58
Physical functioning 98,47 8,93 88,52 21,78 0,043 1,11
Limitations due to emotional as-
pects
97,42 8,76 85,85 23,05 0,031 1,32
Limitations due to the physical 
function
98,06 12,13 86,23 21,70 0,019 0,97
Bodily pain or discomfort 96,96 9,28 70,43 19,88 0,000 2,86
Behavior 78,17 12,52 65,46 19,74 0,007 1,01
General behavior 85,00 16,13 75,65 25,37 0,108 0,58
Mental health 78,95 11,85 70,87 17,17 0,014 0,68
Self-esteem 93,06 13,46 82,44 23,35 0,048 0,79
Perception of health 79,01 11,90 64,00 17 0,000 1,26
Change in health 67,54 23,84 84,78 19,57 0,001 -0,72
Emotional impact on parents 83,70 21,93 63,76 30,42 0,007 0,91
Time impact on parents 93,30 15,85 79,03 27,74 0,030 0,90
Limitations in family activities 89,19 14,26 82,71 17,95 0,081 0,45
Family cohesion 78,48 18,28 61,09 30,78 0,016 0,95
Summary score of physical health 56,65 5,33 46,89 10,53 0,000 1,83
Summary score of psychosocial 
health
54,03 6,54 48,23 7,72 0,001 0,89
* Student’s t test
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studies of adults and children.17,18,21 The lowest score was 
found in the control group in the change in health scale, 
as expected for a healthy population with no change in 
health across time.
Some studies16,20,21,32 have documented AR-related 
situations that caused most discomfort to patients: nasal 
symptoms, associated symptoms (headache, tearing, incre-
ased thirst, weariness/fatigue, concentration difficulty, in-
somnia); emotions (irritation, frustration due to limits cau-
sed by the disease on daily activities, disquiet, impatience, 
anger, nervousness, shame due to nasal symptoms), and 
practical problems (repeatedly scratching and blowing the 
nose, carrying handkerchiefs, using medication).
In children, nasal symptoms and practical matters 
may bother school colleagues and cause embarrassment 
and labeling. Schoolwork may be affected due to dis-
traction, fatigue, irritability, side effects of medication, 
or absenteeism. Therapeutic control measures to avoid 
contact with allergens may limit recreational activities 
and contact with colleagues, leading to social isolation.4
A Brazilian study of teenagers showed that physical 
symptoms (mostly nasal), rather than emotional factors, 
were the most frequently mentioned items as causing 
discomfort. Other discomfort factors mentioned were 
weariness, malaise, thirst, anxiety, nervousness, use of me-
dication, and embarrassing situations due to symptoms.22
The results of family-related domains indicate that 
the disease has a negative impact on the family. Studies 
of chronic diseases in childhood have shown that these 
conditions may affect the QOL of families as follows: 
lack of sleep, fatigue, absence from work, cancellation of 
vacations, interference on social life, and financial costs. 
Some parents may feel guilt, become anxious or over-
protective, or even hostile towards the child, which may 
have a negative effect on the family group.4,33
The correlation between the AVS and the change 
in health domain suggest that increased discomfort due 
to AR as perceived by the child is correlated with a poo-
rer perception of improvement in health as seen by the 
parents, which may be a challenge for successful therapy 
in patients with greater discomfort.
Non-agreement between general behavior and 
behavior scales in the correlation with the AVS may be 
due to a different approach towards the theme; the former 
scale compares the child’s behavior with that of other 
children in one item only, while the latter includes five 
situations, questioning the child’s behavior in each one. 
These results suggest that parents do not perceive beha-
vior differences when comparing their children with other 
children, although they may be able to report a worse 
Table 4. Correlation among CHQ-PF50 scores and the analog visual scale
Scales and summaries - CHQ-PF50
AVS
r p-value
General health 0,10 0,62
Physical functioning 0,32 0,12
Limitations due to emotional aspects 0,24 0,28
Limitations due to the physical function 0,29 0,17
Bodily pain or discomfort -0,34 0,11
Behavior 0,05 0,82
General behavior 0,42 0,04
Mental health 0,22 0,29
Self-esteem 0,13 0,54
Perception of health -0,04 0,84
Change in health -0,52 0,00
Emotional impact on parents 0,28 0,19
Time impact on parents 0,30 0,16
Limitations in family activities 0,17 0,42
Family cohesion -0,11 0,60
Summary score of physical health 0,15 0,49
Summary score of psychosocial health 0,09 0,68
AVS = analog visual scale
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behavior in daily situations. Specific instruments evalua-
ting this domain may provide more accurate information.
Limitation of this study
Although genetic studies of the HRQL make it possi-
ble to compare patients with different chronic conditions, 
they may be indifferent to changes in specific conditions, 
since their focus is not a specific disease.9 This methodo-
logical limitation, inherent to generic instruments, may 
explain the conflicting results we found.
A representative filling in a HRQL questionnaire is a 
situation that, a priori, conflicts with the underlying princi-
ple of seeking an evaluation by the patient him or herself 
about their status. Children vary in the development of 
basic understanding of meanings and functions of the 
words health and disease, which may preclude effective 
communication. Agreement among answers by children 
and those of parents or guardians remains controversial, 
but has been confirmed in some studies.10,34
AR often is associated with other allergies, espe-
cially asthma. Our study aimed, however, to investigate 
the impact of AR singly. Such rigor in the inclusion criteria 
restricted the participation of subjects with other atopic 
conditions, which was reflected in the sample size.
CONCLUSION
AR causes a global negative impact on the HRQL of 
children and teenagers, altering mostly the physical func-
tion, according to the perception of parents or guardians, 
and affects negatively the family group.
REFERENCES
 1. Juniper EF. Can quality of life be quantified? Clin Exp All Rev. 
2002;2(2):57-60.
 2. Juniper EF. Impact of upper respiratory allergic diseases on quality 
of life. J Allergy Clin Immunol. 1998;101 Suppl 2:386-91.
 3. Thompson A, Juniper EF, Meltzer EO. Quality of life in pa-
tients with allergic rhinitis. Ann Allergy Asthma Immunol. 
2000;85(5):338-48.
 4. Meltzer EO. Quality of life in adults and children with allergic 
rhinitis. J Allergy Clin Immunol. 2001;108 Suppl 1:45-53.
 5. De Graff-in ’t Veld T, Koenders S, Gerrelds IM, Gerth Van Wijk R. 
The relationships between nasal hyper reactivity, quality of life, 
and nasal symptoms in patients with perennial allergic rhinitis. 
J Allergy Clin Immunol. 1996;98(3):508-13. 
 6. Juniper EF. Measuring health-related quality of life in rhinitis. J 
Allergy Clin Immunol. 1997;99 Suppl 2:742-9.
 7. The WHOQOL Group. The World Health Organization Quality 
of Life Assessment (WHOQOL): position paper from the World 
Health Organization. Soc Sci Med. 1995;41:1403-9. 
 8. Gerth Van Wijk R. Allergy: A global problem. Quality of life. 
Allergy. 2002;57(12):1097-110.
 9. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related 
quality of life. Ann Intern Med. 1993;118(8):622-9.
10. Jenney MEM, Campbell S. Measuring quality of life. Arch Dis 
Child. 1997;77(4):347-54.
11. Consenso sobre rinites. Rev Bras Otorrinolaringol. 2000;66 Suppl 
10:4-34.
12. Guimarães R, Ceccon CL, Fernandes DT, Pinto LF, Faria TL, 
Ambrosio MR et al. Prevalência da rinite alérgica em escolares 
de 6 a 7 anos na cidade de Uberlândia, ISAAC fase 3. Anais da 
XVI Semana Científica da Medicina;2003 Set 17-20;Uberlândia, 
Brasil. p. 31.
13. Scadding GK, Bousquet J. Introduction. Allergy. 2007;62 Suppl 
85:3-5.
14. Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. 
A survey of the burden of allergic rhinitis in Europe. Allergy. 
2007;62 Suppl 85:17-25.
15. Schatz M. A survey of the burden of allergic rhinitis in the USA. 
Allergy. 2007;62 Suppl 85:9-16.
16. Juniper EF, Guyatt GH. Development and testing of a new me-
asure of health status for clinical trials rhinoconjunctivitis. Clin 
Exp Allergy. 1991;21(1):77-83.
17. Bousquet J, Bullinger M, Fayol C, Marquis P, Valentin B, Burtin 
B. Assessment of quality of life in patients with perennial allergic 
rhinitis with the French version of the SF-36 health status ques-
tionnaire. J Allergy Clin Immunol. 1994;94(2 Pt 1):182-8.
18. Meltzer EO, Nathan RA, Selner JC, Storms W. Quality of life and 
rhinitic symptoms: Results of a nationwide survey with the SF-
36 and RQLQ questionnaires. J Allergy Clin Immunol. 1997;99 
Suppl:815-9.
19. Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality 
of life in allergic rhinitis and asthma. A population-based study 
of young adults. Am J Respir Crit Care Med. 2000;162(4):1391-6.
20. Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life 
in adolescents with allergic rhinoconjunctivitis: development 
and testing of a questionnaire for clinical trials. J Allergy Clin 
Immunol. 1994;93(2):413-23. 
21. Juniper EF, Howland WC, Roberts NB, Thompson AK, King DR, 
Math B. Measuring quality of life in children with rhinoconjunc-
tivitis. J Allergy Clin Immunol. 1998;101(2 Pt 1):163-70.
22. Silva MGN. Adaptação e validação do questionário “RQLQ” para 
avaliação da qualidade de vida em crianças e adolescentes com 
rinite alérgica [tese de mestrado]. São Paulo(SP): Universidade 
Federal de São Paulo;1999.
23. Passalacqua G, Canônica GW, Baiardini I. Rhinitis, rhinosinusitis 
and quality of life in children. Pediatr Allergy Imunnol. 2007;18 
Suppl 18:40-5.
24. Kremer B, Klimek L, Bullinger M, Mösges L. Generic or disease-
specific quality of life scales to characterize health status in allergic 
rhinitis? Allergy. 2001;56:957-63.
25. Landgraf JM, Abetz L, Ware JE Jr. The Child Health Questionnaire: 
A user’s manual. 2nd ed. Boston (MA): The Health Act;1999.
26. Machado CSM, Ruperto N, Silva CHM, Ferriani VPL, Roscoe I, 
Campos LMA et al. For the Pediatric Rheumatology International 
Trials Organization (PRINTO) The Brazilian version of the Chil-
dhood Health Assessment Questionnaire (CHAQ) and the Child 
Health Questionnaire (CHQ). Clin Exp Rheumatol. 2001;19 Suppl 
23:25-9.
27. Gomes DC. Adaptação e validação para a língua portuguesa do 
questionário genérico de avaliação de qualidade de vida - “50-
item, parent complete short form, Child Health Questionnaire” 
(CHQ-PF50) [tese de mestrado]. Uberlândia (MG): Universidade 
Federal de Uberlândia;2001.
649
Brazilian Journal of otorhinolaryngology 75 (5) SeptemBer/octoBer 2009
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
28. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, To-
gias A et al. Allergic rhinitis and its impact on asthma (ARIA) 
2008 update (in collaboration with World Health Organization, 
GA2LEN and AllerGen). Allergy .2008;63 Suppl 86:8-160.
29. Health outcomes methodology symposium. Glossary Med Care. 
2000;38 Suppl 2:7-13. 
30. Landgraf JM, Maunsell E, Speechley KN, Bullinger M, Campbell 
S, Abetz L, et al. Canadian-French, German and UK versions of 
the Child Health Questionnaire: methodology and preliminary 
item scaling results. Qual Life Res. 1998;7(5):433-45.
31. Morales NMO, Silva CHM, Frontarolli AC, Araújo RRH, Rangel VO, 
Pinto RMC et al. Psychometric properties of the initial Brazilian 
version of the CHQ-PF50 applied to the caregivers of children and 
adolescents with cerebral palsy. Qual Life Res. 2007;16(3):437-44.
32. Meltzer EO. Does rhinitis compromise night-time sleep and 
daytime productivity? Clin Exp All Rev. 2002;2(2):67-72.
33. Mccormick MC, Stemmler MM, Athreya BH. The impact of 
childhood rheumatic diseases on the family. Arthritis Rheum. 
1986;29(7):872-9.
34. Eiser C, Morse R. The measurement of quality of life in chil-
dren: past and future perspectives. J Dev Behav Pediatr. 2001; 
22(4):248-56.
